TMEM65 and congestive heart failure: This reduction in Tmem65 leads to clear signs of congestive heart failure (CHF)—including dilated ventricle with fibrosis, reduced cardiac output, increased expression in protein stress markers - by 6–7 weeks post injection, with all mice expiring 7 weeks post injection.